Categories: Latest

Mabion S.A. faces international challenges and welcomes new President of the Board

Artur Chabowski, member of the Board at Mabion S.A. took over as President of the Board on 14 December 2016. He will replace Maciej Wieczorek who served as President of the Board for many years and who will join the Supervisory Board as well as take over management of the Company’s Scientific & Advisory Board.

New Delhi, December 30, 2016: Maciej Wieczorek: My decision to resign from the position of President of the Board is due to the fact that we have completed a certain stage of development which was marked by the conclusion of a partnering contract regarding MabionCD20 for EU member states and the Balkan countries. The next stages, i.e. extensive international efforts, obtaining a USA partner and increasing our international presence need to be managed by a person who will be fully committed and whose competences will ensure successful carrying out of these objectives. My decision, and the fact that it was taken now, is also related to my numerous professional obligations, as well as the October IPO of Celon Pharma S.A., where I am the main shareholder and President of the Board. This scenario was adopted at the very beginning, as Mabion was being established.

Maciej Wieczorek will continue to actively shape the Company’s business strategy in terms of development and commercialisation of new therapies in collaboration with the Management Board by joining the Supervisory Board and chairing the Company’s Scientific & Advisory Board, as well as participating in the company’s strategic decisions.

Artur Chabowski has been associated with Mabion since the very beginning, as a shareholder and member of the Supervisory Board. As member of the Board he has been actively participating in the process of managing the Company for over a year now; furthermore he played a crucial role in the process of acquiring a partner for EU member states and the Balkan countries in relation to MabionCD20. The responsibilities will therefore be handed over smoothly and without and without disruption to the operations of the Company. There is no doubt in my mind as to Artur’s readiness to take over as President; his skills and experience are crucial to the business goals Mabion S.A. is currently facing. – Maciej Wieczorek added.

New challenges – a new President of the Board

Artur Chabowski is an experienced manager with over 20 years of experience in management organisation, international financing and investment banking. He executed numerous international mergers and acquisitions and capital market financing transactions in Poland and other ECC countries. He graduated from the Organisation and Management Department at the Warsaw University of Technology and post-graduate studies at the Woodrow Wilson School of Public and International Affairs, Princeton University.

Artur Chabowski, President of the Board, Mabion S.A.: Mabion is an ambitious and unique project which I have been associated with for many years now; I strongly believe it will be a successful venture. Mabion is also a very effectively managed organisation which brings together people with unique competencies. It is my ambition to ensure intensive development of the Company, both domestically and abroad. Maciej Wieczorek remains a very important person in the organisation and will continue to co-create the Company’s business strategy. We are facing important international challenges arising not only from the concluded partnering contract, but also our plans to obtain partners for markets in the USA and Canada. This is what I would like to focus on in the coming months.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

CARE Hospitals, Nampally, Hosts the 12th National Infection Prevention and Control (IPC) Certificate Program

Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…

3 hours ago

61-Year-Old African Doctor morbidly Obese successfully treated for End-Stage Renal Disease via Robot-Assisted Kidney Transplant at Fortis Hospital Cunningham Road

Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…

3 hours ago

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

1 day ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

1 day ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

2 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

2 days ago